Trademark: 79346494
Status Date
Tuesday, November 7, 2023
Registration Number
7209551
Registration Date
Tuesday, November 7, 2023
Filing Date
Tuesday, May 17, 2022
Published for Opposition
Tuesday, August 22, 2023
40 Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials, namely, processing of biopharmaceutical materials; processing of pharmaceutical preparations; custom manufacture of pharmaceuticals; preservation of pharmaceuticals; processing of medical products, namely, chemical processing of pharmaceuticals; processing of chemicals; chemical treatment of liquid pharmaceutical preparations; chemical processing of medicinal materials
5 Biosimilar pharmaceuticals for the treatment of cancer and prevention of viruses; human immune globulin for the treatment of cancer and prevention of viruses; antibodies for medical purposes for treatment of viral and infectious diseases; pharmaceutical preparations, namely, immunomodulators for the treatment of cancer and prevention of viruses; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer and prevention of viruses; pharmaceutical compositions for the treatment of cancer and prevention of viruses; pharmaceutical biosimilars for human use for the treatment of cancer and prevention of viruses; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; biosimilar pharmaceuticals for the treatment of cancer; human vaccine preparations; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; viral vaccines; pharmaceutical products for the treatment of viral diseases; anti-viral agents
1 Biological preparations, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; reagents for scientific or medical research use; cell growth media for growing cells for use in scientific research; biochemical preparations, namely, monoclonal antibodies for scientific purposes; markers being biological preparations for analyzing proteins for scientific or laboratory purposes; reagents for analyzing proteins for scientific or laboratory purposes; protein preparations for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes; nucleic acid preparations for scientific or laboratory purposes; buffer solutions for scientific purposes; cultures of microorganisms for scientific or laboratory purposes; cells for scientific or laboratory purposes; cultures of microorganisms for character change for scientific or laboratory purposes
42 Development of biologics; design of biologics; research of biologics; research and development services in the field of engineering; providing advice in the field of technological research relating to pharmaceutical manufacturing process technology; scientific and technological services, namely, scientific research, medical and scientific research, pharmaceutical screening for scientific research purposes, biological research; development of industrial processes; industrial process research in the field of pharmaceuticals and biological research; research relating to the computerised automation of technical processes; research relating to the computerised automation of industrial processes; quality control for others; process monitoring for quality assurance in the field of pharmaceuticals; research and development of devices for chemical processing; research and development of pilot equipment for chemical processing; consultancy in the field of engineering; providing consultation, advice, and information in the field of engineering research; product research and development in the fields of products for the treatment of viral and infectious diseases, products for the treatment of cancer, viral vaccines, pharmaceutical products for the treatment of viral diseases, and anti-viral agents
Mar 4, 2024
Final Decision Transaction Processed By Ib
Feb 8, 2024
Final Disposition Notice Sent To Ib
Feb 8, 2024
Final Disposition Processed
Feb 7, 2024
Final Disposition Notice Created, To Be Sent To Ib
Nov 7, 2023
Notice Of Registration Confirmation Emailed
Nov 7, 2023
Registered-Principal Register
Aug 22, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2023
Published For Opposition
Aug 21, 2023
Notification Processed By Ib
Aug 2, 2023
Notification Of Possible Opposition Sent To Ib
Aug 2, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 2, 2023
Notification Of Notice Of Publication E-Mailed
Jul 17, 2023
Approved For Pub - Principal Register
Jul 17, 2023
Examiner's Amendment Entered
Jul 17, 2023
Notification Of Examiners Amendment E-Mailed
Jul 17, 2023
Examiners Amendment E-Mailed
Jul 17, 2023
Examiners Amendment -Written
Jun 20, 2023
Teas/Email Correspondence Entered
Jun 20, 2023
Correspondence Received In Law Office
Jun 20, 2023
Teas Response To Office Action Received
May 24, 2023
Refusal Processed By Ib
May 3, 2023
Non-Final Action Mailed - Refusal Sent To Ib
May 2, 2023
Refusal Processed By Mpu
Mar 14, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Mar 13, 2023
Non-Final Action Written
Mar 7, 2023
Assigned To Examiner
Aug 9, 2022
Application Filing Receipt Mailed
Aug 5, 2022
New Application Office Supplied Data Entered
Aug 4, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
